Katie Rodriguez
Gerontology · Roslyn, NYNPI 1821575309
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $635 and has fallen 56.3% since, to $277 in 2025.
Across 133 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$523
- AbbVie$487
- Astellas Pharma US Inc$233
- Pfizer$215
- Exact Sciences$206
- GSK$114
- plus $632 from 12 others
What the payments were for
- Food & beverage$2,31696%
- Education$944%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 35 | $523 |
| AbbVie | 28 | $487 |
| Astellas Pharma US Inc | 8 | $233 |
| Pfizer | 10 | $215 |
| Exact Sciences | 10 | $206 |
| GSK | 6 | $114 |
| Novo Nordisk | 5 | $113 |
| AstraZeneca | 6 | $105 |
| Esperion Therapeutics, Inc. | 5 | $83 |
| Merck | 3 | $51 |
| Eisai Inc. | 2 | $44 |
| Genentech USA, Inc. | 5 | $41 |
| Renalytix AI, Inc. | 2 | $39 |
| Idorsia Pharmaceuticals US Inc | 2 | $38 |
| Althera Pharmaceuticals LLC | 2 | $37 |
| Boehringer Ingelheim | 2 | $35 |
| Amgen | 1 | $25 |
| Sanofi Pasteur Inc. | 1 | $21 |
How this compares
$2,410 in reported general payments places this provider in the 85th percentile of 187 gerontology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 53 | $62,196 |
| EliquisApixaban | 39 | $45,152 |
| PancreazeLipase/Protease/Amylase | 13 | $44,259 |
| JanuviaSitagliptin Phosphate | 37 | $36,834 |
| OzempicSemaglutide | 33 | $33,736 |
| XareltoRivaroxaban | 14 | $15,492 |
| TrulicityDulaglutide | 13 | $12,259 |
| SynthroidLevothyroxine Sodium | 96 | $7,791 |
| Rosuvastatin Calcium | 375 | $6,194 |
| NexletolBempedoic Acid | 11 | $4,704 |
| Atorvastatin Calcium | 364 | $3,349 |
| Levothyroxine Sodium | 196 | $2,424 |
| Metoprolol Succinate | 149 | $2,293 |
| Losartan Potassium | 192 | $2,075 |
| Irbesartan | 40 | $1,636 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $35 | $62,19653 claims |
| PfizerEliquis | $215 | $45,15239 claims |
| MerckJanuvia | $51 | $36,83437 claims |
| Novo NordiskOzempic | $113 | $33,73633 claims |
| AbbVieSynthroid | $487 | $7,79196 claims |
| Esperion Therapeutics, Inc.Nexletol | $83 | $4,70411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 187 gerontology providers in New York.
Other gerontology in Roslyn
- Michael HunterRoslyn$1K
- Amy YatesRochester$23K
- Kristen BattiatoStaten Island$15K
- Kathy SimoneNew York$6K
- Donna DohertyNew Hyde Park$6K
- Laping XuNew York$6K
- Aslihan YurdaozRochester$5K
- Kennedy O'HaraUniondale$5K
- Dan Ai LiuNew York$5K
- Marceline CookPoughkeepsie$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.